RÉFÉRENCES
BIBLIOGRAPHIQUES
1. Grant D, Wall W, Mimeault R et al. Successful
small-bowel/liver transplantation. Lancet 1990 ;
335 : 181-4.
2. Lee RG, Nakamura K, Tsamandas AC et al.
Pathology of human intestinal transplantation.
Gastroenterology 1996 ; 100 : 1820-34.
3. Reyes J, Bueno J, Kocoshis S et al. Current status
of intestinal transplantation in children. J Pediatr
Surg 1998 ; 33 : 243-54.
4. Reyes J, Mazariegos GV, Bond GM et al. Pediatric
intestinal transplantation : historical notes, prin-
ciples and controversies. Pediatr Transplant 2002 ;
6:193-207.
5. Reyes J, Todo S, Green M et al. Graft-versus-host
disease after liver and small bowel transplantation in
a child. Clin Transplant 1997 ; 11 : 345-8.
6. Watanabe M, Ueno Y,Yajima T et al. Interleukin 7
is produced by human intestinal epithelial cells and
regulates the proliferation of intestinal mucosal lym-
phocytes. J Clin Invest 1995 ; 95 : 2945-53.
7. Reinecker HC, MacDermott RP, Mirau S, Dignass
A, Podolsky DK. Intestinal epithelial cells both
express and respond to interleukin 15. Gastroente-
rology 1996 ; 111 : 1706-13.
8. Dvinell MB, Lusering N, Eckmann L, Kagnoff MF.
Regulated production of interferon-inducible T cell
chemoattractants by human intestinal epithelial
cells. Gastroenterology 2001 ; 120 : 49-59.
9. Sarnacki S, Nakai H, Calise D et al. Decrease
expression of the IL-2 receptor on CD8+ recipient
lymphocytes in intestinal grafts rendered tolerant by
liver transplantation in rats. Gut 1998 ; 30 : 849-55.
10. Azuma T, Sarnacki S, Révillon Y et al. Study of
graft infiltrating cells in a rejection model of small
bowel transplantation in rats. Transplant Proc
1994 ; 26 : 1523-4.
11. Toogood GJ, Rankin AM, Tam PK, Morris PJ,
Dallman MJ. The immune response following small
bowel transplantation. II. A very early cytokine res-
ponse in the gut-associated lymphoid tissue.
Transplantation 1997 ; 63 : 1118-23.
12. Zhang Z, Kaptanoglu L, Haddad W et al. Donor T
cell activation initiates small bowel allograft rejection
through an IFN-gamma-inducible protein 10-depen-
dent mechanism. J Immunol 2002 ; 68 : 3205-12.
13. El-Sawy T, Fahmy NM, Fairchild RL.
Chemokines : directing leukocyte infiltration into
allografts. Curr Opin Immunol 2002 ; 14 : 562-8.
14. Quan D, Grant DR, Zhong RZ, Zhang Z, Garcia
BM, Jevnikar AM. Altered gene expression of cyto-
kine, ICAM-1, and class II molecules precedes mouse
intestinal allograft rejection. Transplantation 1994 ;
58 : 808-16.
15. McDiarmid SV, Farmer DG, Kuniyoshi JS et al.
The correlation of intragraft cytokine expression with
rejection in rat small intestine transplantation.
Transplantation 1994 ; 58 : 690-7.
16. McDiarmid SV, Farmer DG, Kuniyoshi JS et al.
Perforin and granzyme B. Cytolytic proteins up-regu-
lated during rejection of rat small intestine allo-
grafts. Transplantation 1995 ; 59 : 762-6.
17. Krams SM, Hayashi M, Fox CK et al. CD8+
cells are not necessary for allograft rejection or the
induction of apoptosis in an experimental model of
small intestinal transplantation. J Immunol 1998 ;
160 : 3673-80.
18. Newell KA, He G, Hart J, Thistletwaite JR Jr.
Treatment with either anti-CD4 or anti-CD8 mono-
clonal antibodies blocks αβT cell-mediated rejection
of intestinal allografts in mice. Transplantation
1997 ; 64 : 959-65.
19. Gorczynski RM, Cohen Z, Levy G, Fu XM. A role
for gamma(delta) TCR+ cells in regulation of rejec-
tion of small intestinal allografts in rats.
Transplantation 1996 ; 62 : 844-51.
20. Khanna A, Cairns V, Hosenpud JD. Tacrolimus
induces increased expression of transforming growth
factor-beta1 in mammalian lymphoid as well as non-
lymphoid cells. Transplantation 1999 ; 67 : 614-9.
21. Larsen CP, Elwood ET, Alexander DZ et al.
Long-term acceptance of skin and cardiac allografts
after blocking CD40 an CD28 pathways. Nature
1996 ; 381 : 434-8.
22. Bemer V, Truffa-Bachi P. T cell activation by
concanavalin A in the presence of cyclosporin A :
immunosuppressor withdrawal induces NFATp
translocation and interleukin-2 gene transcription.
Eur J Immunol 1996 ; 26 : 1481-8.
23. Chen H, Qi S, Xu D, Wu J, Daloze P. The immuno-
suppressive effect of rapamycin on mouse small
bowel transplantation. Transplantation 1996 ; 61 :
523-6.
24. Kahan BD, Camardo JS. Rapamycin : clinical
results and future opportunities. Transplantation
2001 ; 72 : 1181-93.
25. Li Y, Li XC, Zheng XX, Wells AD, Turka LA,
Strom TB. Blocking both signal 1 and signal 2 of
T-cell activation prevents apoptosis of alloreactive
cells and induction of peripheral allograft tolerance.
Nature Med 1999 ; 5 : 1298-302.
26. Sollinger HW. From mice to man : the preclini-
cal history of mycophenolate mofetil. Clin Transpl
1996 ; 10 : 85-92.
27. Misiakos EP, Weppler D, Bakonyi A et al.
Clinical outcome of intestinal transplantation at the
University of Miami. Transplant Proc 1999 ; 31 :
569-71.
28. Ducloux D, Ottignon Y, Semhoun-Ducloux S et
al. Mycophenolate mofetil-induced villous atrophy.
Transplantation 1998 ; 66 : 1115-66.
29. Murase N, Ye Q, Lee RG et al. Immunomodula-
tion of intestinal transplant with allograft irradiation
and simultaneous donor bone marrow infusion.
Transpl Proc 1999 ; 31 : 565-6.
30. Wang M, Qu X, Stepkowski M. Beneficial effect
of graft perfusion with anti-T cell receptor monoclo-
nal antibodies on survival of small bowel allografts
in rat recipients treated with brequinar alone or in
combination with cyclosporine and sirolimus.
Transplantation 1996 ; 61 : 458-64.
31. Langnas AN, Shaw BW, Antonson DL et al.
Preliminary experience with intestinal transplanta-
tion in infants and children. Pediatrics 1996 ; 97 :
443-8.
32. Douillard P, Vignes C, Josien R et al.
Reassessment of the role of CD8+ T cells in the
induction of allograft tolerance by donor-specific
blood transfusion. Eur J Immunol 1999 ; 29 : 1919-
24.
33. Josien R, Douillard P, Guillot C et al. A critical
role for transforming growth factor-ß in donor trans-
fusion-induced allograft tolerance. J Clin Invest
1998 ; 102 : 1920-6.
34. Turvey SE, Fry JW, Wood KJ. New insights on
the mechanisms of acquired intrathymic tolerance.
Curr Opin Organ Transplant 1999 ; 4 : 50-7.
35. Sun S, Greenstein SM, Schechner RS, Tellis VA.
Prolonged small bowel allograft survival following
repeated intrathymic injections of donor splenocytes
and peripheral anti-lymphocyte treatment. Trans-
plant Proc 1999 ; 31 : 588-9.
36. Kamada N. The immunology of experimental
liver transplantation in the rat. Immunology 1985 ;
55 : 369-89.
37. Sarnacki S, Revillon Y, Cerf-Bensussan N,
Calise D, Goulet O, Brousse N. Long-term small-
bowel graft survival induced by spontaneously tole-
rated liver allograft in inbred rat strains.
Transplantation 1992 ; 54 : 383-5.
38. Bishop GA, Sharland AF, McCaughan GW.
High-dose/activation-associated tolerance model for
allografts : lesson from spontaneous tolerance of
transplanted livers. Curr Opin Organ Transplant
1999 ; 4 : 58-64.
39. Zavazava N, Krönke M. Soluble class I mole-
cules induce apoptosis in alloreactive cytotoxic T
lymphocytes. Nature Med 1996 ; 2 : 1005-10.
40. Sriwatanawongsa V, Davies HS, Calne RY. The
essential roles of parenchymal tissues and passenger
leukocytes in the tolerance induced by liver grafting
in rats. Nature Med 1995 ; 1 : 428-32.
41. Bertolino P, Trescol-Biemont MC, Rabourdin-
Combe C. Hepatocytes induce functional activation
of naive CD8+ T lymphocytes but fail to promote sur-
vival. Eur J Immunol 1998 ; 28 : 221-36.
42. Thomson AW. Are dendritic cells the key to liver
transplant tolerance ? Immunol Today 1999 ; 20 :
27-32.
43. Khanna A, Morelli AE, Zhong C, Takayama T,
Lu L, Thomson AW. Effects of liver-derived dendritic
cell progenitors on Th1- and Th2-like cytokine res-
ponses in vitro and in vivo. J Immunol 2000 ; 64 :
346-54.
44. Qian S, Lu L, Fu F et al. Apoptosis within sponta-
neously accepted mouse liver allografts. Evidence for
deletion of cytotoxic T cells and implications
for tolerance induction. J Immunol 1997 ; 158 : 4654-61.
Le Courrier de la Transplantation - Volume II - n o4 - oct.-nov.-déc. 2002
166
DOSSIER
thématique